SALONI PATEL: Open Payments
NPI 1598713067 · OAKLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,554 in 58 payments from 15 companies in 2025. Trend: 2023 $1,980 · 2024 $1,686 · 2025 $1,554
Food & beverage: $1,474Education: $80
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $323 |
| Janssen Biotech, Inc. | 8 | $294 |
| GENZYME CORPORATION | 5 | $181 |
| Incyte Corporation | 6 | $160 |
| UCB, Inc. | 5 | $100 |
| Regeneron Healthcare Solutions, Inc. | 4 | $96 |
| Lilly USA, LLC | 3 | $93 |
| Galderma Laboratories, L.P. | 3 | $59 |
| Organon LLC | 2 | $47 |
| Arcutis Biotherapeutics, Inc. | 2 | $45 |
Products named: TREMFYA, DUPIXENT, OPZELURA, VRAYLAR, Bimzelx, SKYRIZI, TALTZ, BOTOX.
Industry payments across CA — which companies pay providers there.
